Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
From MaRDI portal
(Redirected from Publication:94249)
This page was built for publication: Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q94249)